NM_001205293.3:c.267-2088C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.267-2088C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.321 in 152,072 control chromosomes in the GnomAD database, including 8,238 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 8238 hom., cov: 33)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.157

Publications

7 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.421 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.267-2088C>T intron_variant Intron 1 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.267-2088C>T intron_variant Intron 1 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.267-2088C>T intron_variant Intron 1 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.267-2088C>T intron_variant Intron 1 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.267-2088C>T intron_variant Intron 1 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.702-2088C>T intron_variant Intron 3 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.321
AC:
48723
AN:
151954
Hom.:
8227
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.426
Gnomad AMI
AF:
0.255
Gnomad AMR
AF:
0.268
Gnomad ASJ
AF:
0.463
Gnomad EAS
AF:
0.345
Gnomad SAS
AF:
0.160
Gnomad FIN
AF:
0.242
Gnomad MID
AF:
0.328
Gnomad NFE
AF:
0.283
Gnomad OTH
AF:
0.335
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.321
AC:
48777
AN:
152072
Hom.:
8238
Cov.:
33
AF XY:
0.314
AC XY:
23306
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.426
AC:
17665
AN:
41446
American (AMR)
AF:
0.268
AC:
4099
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.463
AC:
1605
AN:
3470
East Asian (EAS)
AF:
0.345
AC:
1779
AN:
5158
South Asian (SAS)
AF:
0.161
AC:
775
AN:
4820
European-Finnish (FIN)
AF:
0.242
AC:
2559
AN:
10578
Middle Eastern (MID)
AF:
0.322
AC:
94
AN:
292
European-Non Finnish (NFE)
AF:
0.283
AC:
19270
AN:
67988
Other (OTH)
AF:
0.331
AC:
698
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1679
3357
5036
6714
8393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.301
Hom.:
21705
Bravo
AF:
0.332
Asia WGS
AF:
0.250
AC:
871
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.40
DANN
Benign
0.54
PhyloP100
-0.16
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs558994; hg19: chr1-181477525; API